Application prospects of phased-array computed tomography in the diagnosis and treatment of digestive system diseases: A cross-sectional survey

Table 2 Potential scores for phased-array computed tomography applications in digestive system diseases

Category	Application scenarios	Mean	SD
Liver	Early detection and differentiation of micro-liver cancer (< 1 cm) in the context of cirrhosis	4.33	0.71
	Early identification of liver metastases	4.32	0.68
	Precise differentiation of benign lesions such as focal nodular hyperplasia and hemangiomas	4.19	0.74
	Non-invasive quantitative assessment of liver fibrosis and cirrhosis	3.98	0.88
Pancreatic	Detection and staging of early pancreatic cancer	4.30	0.73
	Accurate assessment of the risk of malignant transformation in pancreatic cysts	4.23	0.72
	Differential diagnosis between chronic pancreatitis and pancreatic cancer	4.21	0.71
	Detailed evaluation of necrosis extent and vascular complications in acute pancreatitis	4.20	0.73
Gastrointestinal	Localization and risk stratification of submucosal tumors in the gastrointestinal tract	4.24	0.69
	Assessment of infiltration depth for early gastrointestinal cancers	4.17	0.77
	Evaluation of activity, extent, and complications (e.g., fistulas) in inflammatory bowel disease	4.16	0.77
Function and dynamic imaging	Quantitative analysis of organ blood perfusion	4.09	0.72
	Dynamic assessment of gastrointestinal motility	3.91	0.82
Interventional and surgical planning	Localization of ablation scope and efficacy assessment for liver and pancreatic tumors	4.42	0.69
	Pre-procedural vascular access planning and post-procedural assessment	4.07	0.74
	Precise preoperative assessment of liver vasculature and volume	4.04	0.74